Metformin is a generic prescription drug that works to treat type 2 diabetes by helping lower your blood sugar levels. Your response to this drug may vary based on your medical history and diagnosis.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Cumulative incidence of noncommunicable diseases was ...
When patients are diagnosed with type 2 diabetes, one of the first questions they usually ask is, “Doctor, why not prescribe ...
The HOME (Hyperinsulinemia: the Outcome of its Metabolic Effects) trial was a randomized, placebo-controlled, multicenter study designed to test the hypothesis that metformin (compared with placebo) ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A risk prediction model assesses seven variables to ...
NEW YORK (Reuters Health) - In people with type 2 diabetes, the combination of two anti-diabetes drugs -- sitagliptin and metformin -- improves blood sugar control in a synergistic fashion, a study ...
In a recent study published in the journal Nutrients, researchers conducted a systematic review of human clinical trials that examined the administration of oral probiotics to improve gut microflora ...
In a recent cohort study published in JAMA Network Open, researchers evaluated whether metformin treatment is associated with a reduced risk of all-cause dementia in people with type 2 diabetes (T2D).
Hosted on MSN
GLP-1 diabetes drugs likely trump metformin for curbing dementia risk in type 2 diabetes, study finds
GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results